logo nano spa 1
  • Cabecera 1
    nanoscience and nanotechnology: small is different
  • Home
  • Metallodrugs to Modulate Cancer Cell Machinery
  • People
  • Dr. Ana María Pizarro Arranz

    Position: Assistant Research Prof. (tenure track)
    PhD: Universidad Autónoma de Madrid, Spain
    Previous Position: University of Warwick (UK)
    Research: Metallodrugs to Modulate Cancer Cell Machinery
    ORCID: 0000-0003-3037-9835
    Researcher ID: L-8348-2014
    Joining Date: January, 2014
    User Name: ana.pizarro
    Telephone: +34 91 299 88 47
    Pizarro Arranz

    Ana M. Pizarro completed a PhD in Chemistry at the Universidad Autónoma de Madrid in 2004 under the supervision of Prof. C. Navarro-Ranninger, working on trans-platinum cytotoxic compounds. She was awarded a Marie Curie Fellowship (EIF) to work in the laboratory of Prof. P. J. Sadler FRS at the University of Edinburgh (UK) on new organometallic ruthenium-based organometallics. She then moved to the University of Warwick (UK) where she focused on how selected metallodrugs (based on ruthenium, osmium and iridium) exert their anticancer effects in tumour cells. In January 2014 she was awarded a Ramón y Cajal Fellowship and joined IMDEA Nanociencia as an Assistant Professor. Her main interest lies in exploiting the extraordinary features of transition metal complexes inside the human cell to modulate its machinery at the molecular level in the nano-space. Additionally, Dr. Pizarro coordinates the Cell Culture Unit and Microbiology at IMDEA Nanociencia. She is one of the ten guarantors of the Severo Ochoa centre of Excellence award at IMDEA Nanociencia. She got tenure in April 2019.

    twitter

  • Dr. Vanessa Rodríguez Fanjul

    Position: Research Staff
    Research: Cell Cultures
    ORCID: 0000-0002-3386-5874
    Researcher ID: K-8417-2017
    Joining Date: July, 2013
    User Name: vanessa.rodriguez
    Rodríguez Fanjul

    Dr. Vanessa Rodríguez Fanjul graduated in Biochemistry from Universidad Autónoma de Madrid (Spain) in 2004. She obtained a PhD in Biochemistry, Molecular Biology and Biomedicine from the same University in 2011 developing her work at the Spanish Research Council (CSIC). She investigated the role of MKP1 protein on carcinogenesis and on the response to carboplatin (CBDCA) of lung and skin cancer by using both, cellular and animal models. In 2013 she joined IMDEA Nanociencia as a Postdoctoral fellow where she studied the cytotoxicity, uptake and distribution mechanisms of magnetic nanoparticles in various cell lines and cancer stem cells from human glioblastoma multiforme (GBM). Currently, she is a post-doctoral researcher in the Laboratory of Metallodrugs at IMDEA Nanociencia, studying the cytotoxic effect and molecular targets (including the mechanism of action) of different metal complexes of Ru, Rh, Os, Ir, Pt and Au.

    twitter

  • Arturo Villechenous Rojo

    Position: PhD Researcher
    Research: Metallodrugs
    ORCID: 0000-0003-2357-7120
    Researcher ID: Y-4012-2019
    User Name: arturo.villechenous
    Villechenous Rojo

    Arturo Villechenous Rojo studied his bachelor's in chemistry at Universidad Complutense de Madrid (Spain) in 2018. He went to the Universidade de Santiago de Compostela to carry out his Master studies on Organic Chemistry at the group of Prof. M. Eugenio Vázquez at CiQUS, working on the field of biological chemistry.

    He is currently working towards a PhD in the field of organometallic chemistry at IMDEA Nanociencia. Arturo's research is mainly focused on rhodium and iridium organometallic complexes for cancer research and the study of these complexes. In particular, he is searching for a strategy to be able to follow the activation and deactivation of switchable organometallic catalysis inside the human cell.

  • Catarina Leis Malvar

    Position: Technician
    Research: Metallodrugs to Modulate Cancer Cell Machinery
    Joining Date: February, 2020
    User Name: catarina.leis
    Leis Malvar

    Catarina Leis obtained a title as Pathological Anatomy and Cytodiagnosis at the Universidade de Santiago de Compostela (USC) in 2018, carrying out the practical work at the Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS) under the supervision of Dr. María Brión at the Department of Genetic Diagnosis of Hereditary Micro-cardiopathies.

    Currently, she provides technical support at the Cell Culture and Microbiology Unit at IMDEA Nanociencia. Additiona

  • Claudia Pierina Cardozo Yusti

    Position: PhD Researcher
    Research: Metallodrugs to Modulate Cancer Cell Machinery
    ORCID: 0000-0001-9164-137X
    Researcher ID: AAF-6156-2021
    User Name: claudia.cardozo
    Cardozo Yusti

    Claudia Cardozo Yusti obtained her Bachelor's degree in Chemistry from the Universidad de Carabobo (Venezuela), after doing her undergraduate resesarch work at the Instituto Venezolano de Investigaciones Científicas (IVIC) in the transition metals chemistry laboratory. She obtained a Master degree in Science - Chemistry, from the Universidad de Los Andes (Colombia), working in the field of bioinorganic chemistry, specifically obtaining potentially anticancer copper and zinc complexes to test their biological action in zebrafish and cancer cells.

    Currently, she is carrying out a PhD research project at IMDEA Nanociencia under the supervision of Dr. Ana Pizarro, funded by the Spanish Ministry under the FPI programme. Her work focuses on obtaining potent anticancer complexes of Ru(II) and Os(II), which will be activated only in the tumor cell, causing its death.

  • Alejandro Martin Hoyas 

    Position: PhD Researcher
    Research: Metallodrugs to Modulate Cancer Cell Machinery
    Joining Date: September 2022
    User Name: alejandro.martinhoyas
    Martin Hoyas 

    Alejandro Martín Hoyas studied his Bachelor’s degree in Chemistry at Universidad Complutense de Madrid (Spain). In 2022 he obtained his MSc degree in the field of nanoscience and nanomaterials in the same university. He carried out his Master’s project in the group of Prof. Reyes Jiménez-Aparicio working in the field of organometallic chemistry, specifically with metal-metal bonded of Ru, Rh and lanthanide complexes.

    Currently, he is carrying out a PhD at IMDEA Nanociencia in the field of bioinorganic and organometallic chemistry under the tutelage of Dr. Ana Pizarro. Alejandro’s research is focused on the synthesis of novel organometallic tethered rhenium complexes with anticancer activity.

  • Sergio Millan Vega

    Position: Technician
    Research: Metallodrugs to Modulate Cancer Cell Machinery
    Joining Date: December 2022
    User Name: sergio.millan
    Millan Vega

    Sergio Millán obtained his titles as Clinical and Biomedical Laboratory Technician in 2019, and followed his studies as Pathological Anatomy and Cytodiagnosis Technician in 2022 from the centre of training studies CESUR-Málaga. For his internships, he worked under the supervision of Dr Iraida Amaya Saavedra at IFAPA-Churriana in the Laboratory of Biochemistry, and at LOGOPAT, laboratory of pathological anatomy.

    In December 2022, Sergio joined IMDEA Nanociencia, supporting the Pizarro group and providing technical support at the Cell Culture and Microbiology Unit.